XClose

UCL News

Home
Menu

Stem-Cell Clinical Trials Move Debate Beyond Labs

13 October 2011

Professor Pete Coffey (UCL Institute of Ophthalmology), in collaboration with Pfizer, is awaiting regulatory permission to begin an embryonic stem cell trial to treat age-related macular degeneration.

Read: Wall Street Journal